IM Cannabis (IMCC) Return on Invested Capital (2022 - 2026)
IM Cannabis (IMCC) recorded quarterly Return on Invested Capital of 0.02% in Q1 2026, down 467.54% quarter-over-quarter from 0.0% in Q4 2025, and down 1.0% on a YoY basis from 0.02% in Q1 2025.
IM Cannabis (IMCC) Return on Invested Capital (2022 - 2026) Analysis & Trends
IM Cannabis' Return on Invested Capital history runs 5 years deep, the most recent figure standing at 0.02% for Q1 2026.
- In Q1 2026, Return on Invested Capital fell 1.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Invested Capital was 0.02% for Q1 2026 at IM Cannabis, down from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 4.49% in Q2 2022 to a low of 0.02% in Q1 2026.
- Historically, Return on Invested Capital has averaged 0.52% across 5 years, with a median of 0.0% in 2024.
- The sharpest annual moves came in 2023 and 2025: Return on Invested Capital slumped 445 bps in 2023, then changed 0 bps in 2025.
- A 5-year view of Return on Invested Capital shows it stood at 0.05% in 2022, then slumped by 105 bps to 0.0% in 2023, then slumped by 184 bps to 0.01% in 2024, then soared by 59 bps to 0.0% in 2025, then sank by 468 bps to 0.02% in 2026.
- The last three Return on Invested Capital figures came in at 0.02% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.01% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.00% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 0.00% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.00% |
| 10 | IM Cannabis | 49,978.63 | -735,375.90 | 1.03 Mn | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.09% |
| Jun 30, 2023 | 0.05% |
| Mar 31, 2023 | 0.05% |
| Dec 31, 2022 | 0.05% |
| Sep 30, 2022 | 3.09% |
| Jun 30, 2022 | 4.49% |
| Mar 31, 2022 | 1.03% |